Cencora (COR) 2026 Global Healthcare Conference summary

Leadership transition and strategic focus

• CFO brings three decades of healthcare experience, emphasizing excitement about returning to the sector and leveraging past partnerships to drive value.

• Transition from previous CFO was smooth, with strong support and a deep finance team in place.

• Surprised by the breadth of services beyond logistics, highlighting opportunities to enable growth for partners.

• Emphasis on balancing integration with maintaining differentiated services, especially in specialty distribution and MSOs.

Market positioning and growth drivers

• Specialty pharmaceutical market innovation and demographic trends are key growth drivers.

• Long-term investments in specialty distribution, GPOs, and MSOs position the business for durable growth.

• MSO segment expected to become a significant contributor to profitability by fiscal 2027, with potential for increased disclosure.

• Strategic discipline in MSO acquisitions, focusing on retina and oncology, while deprioritizing non-strategic opportunities.

Industry trends and competitive landscape

• Market stability expected as MSO acquisition activity slows and transitions annualize.

• Ongoing small-scale MSO additions, primarily independent practices, rather than headline-grabbing deals.

• No major churn anticipated in the customer base, with a stable competitive environment.